Glytec's Chief Medical Officer Honored for Patient Safety Excellence
Glytec's Chief Medical Officer Honored for Patient Safety Excellence
Glytec, a trailblazer in AI-driven diabetes management technology, has made headlines as its Chief Medical Officer, Dr. Jordan Messler, MD, SFHM, FACP, was recognized by Becker's Hospital Review as one of the prestigious names among the "Patient Safety Experts to Know" in 2025. This acknowledgment underscores Dr. Messler's commitment to enhancing patient safety practices and healthcare quality.
Recognizing Leadership in Patient Safety
The annual recognition by Becker's highlights the contributions of 132 leaders across the nation who are pivotal in improving patient safety. These experts specialize in preventing hospital-acquired infections and minimizing adverse events, working tirelessly to ensure healthcare facilities adhere to high regulatory standards. Their efforts play a crucial role in shielding patients from potential risks and uncertainties that can lead to complications and critical incidents.
Dr. Messler's Impact on Diabetes Management
Dr. Messler has been a driving force in advancing diabetes care and glycemic control. He emphasizes the significance of employing cutting-edge technology that complies with FDA safety protocols. Under his guidance, Glytec has rolled out Glucommander®, an innovative insulin dosing solution fully integrated into electronic health records (EHR), aimed at mitigating the dangers of hyperglycemia and hypoglycemia. These two conditions are increasingly essential components in forthcoming CMS reporting initiatives.
Remarkable Outcomes Through Innovation
Through his leadership, Glytec has demonstrated that Glucommander® produces tangible benefits, notably a reduction in hypoglycemic episodes, shorter durations of hospital stays, and decreased rates of patient readmissions. The solution boasts an impressive return on investment, averaging 6-8 times. Dr. Messler's extensive hospital experience has enabled him to streamline Glytec's offerings, ensuring they align seamlessly with healthcare providers' IT infrastructures, thereby enhancing clinical workflows and delivering comprehensive analytics.
Dr. Patrick Cua, CEO of Glytec, expressed pride in Dr. Messler's recognition, stating, "Patient safety is at the heart of everything we do at Glytec. This honor highlights our collective mission and reinforces our dedication to providing healthcare professionals with resources essential for delivering innovative and safe patient care."
Glytec's Continued Commitment to Excellence
The acknowledgment of Dr. Messler comes on the heels of several accolades for Glytec in 2025, including triumphing as the Gold Stevie® Award winner for Healthcare Technology Company of the Year. This recognition showcases Glytec's relentless pursuit of excellence within the healthcare technology sector.
About Glytec
Glytec is renowned for its AI-powered technology platform, utilized by over 400 hospitals nationwide. The platform fosters effective diabetes management and insulin dosing while enhancing patient outcomes, diminishing the length of hospital stays, and decreasing readmissions. Glytec's flagship product, Glucommander®, is the first FDA-cleared cloud-based insulin management software. By integrating with various electronic medical records, it delivers advanced clinical support, timely alerts, and thorough analytics to improve patient care. With a robust portfolio of over 100 patents and countless peer-reviewed publications, Glytec is committed to transforming care from hospitals to homes.
Frequently Asked Questions
Who was recognized by Becker's Hospital Review in 2025?
Dr. Jordan Messler, Chief Medical Officer of Glytec, was recognized as one of the "Patient Safety Experts to Know" by Becker's Hospital Review in 2025.
What is Glucommander®?
Glucommander® is Glytec's FDA-cleared software for insulin dosing, designed to reduce the risks associated with diabetes management in healthcare settings.
What are the benefits of Glucommander®?
Benefits of Glucommander® include a reduction in hypoglycemic events, shorter hospital stays, lower readmission rates, and a substantial return on investment for healthcare providers.
Why is patient safety important in healthcare?
Patient safety is crucial in healthcare to minimize risks such as hospital-acquired infections and adverse events that can lead to serious health complications.
What has Glytec achieved in 2025?
In 2025, Glytec was awarded the Gold Stevie® Award for Healthcare Technology Company of the Year, reflecting its commitment to excellence and innovation in patient care.
About The Author
Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.